JavaScript is disabled for your browser. Some features of this site may not work without it.
We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.
| dc.contributor.author | Visser, Adele
|
|
| dc.contributor.author | Hoosen, Anwar Ahmed
|
|
| dc.date.accessioned | 2012-12-12T11:33:05Z | |
| dc.date.available | 2012-12-12T11:33:05Z | |
| dc.date.issued | 2012-01 | |
| dc.description.abstract | Human papillomavirus (HPV) infection has been estimated to cause 270 000 deaths worldwide annually from cervical cancer and approximately 80% of these occur in resource-poor countries.1 In South Africa, cervical cancer is the second most common malignancy among women, with the highest rate among black women aged 66 - 69 years.2 With the development of prophylactic HPV vaccines there are prospects of significant reduction in morbidity and mortality due to HPV infection and its complications. | en_US |
| dc.description.uri | http://www.cmej.org.za/index.php/cmej | en_US |
| dc.identifier.citation | Visser, A & Hoosen, A 2012, 'Human papillomavirus (HPV) vaccines', CME : Continuing Medical Education, vol. 30, no. 1, pp. 29. | en_US |
| dc.identifier.issn | 1016-6742 (print) | |
| dc.identifier.issn | 2078-5143 (online) | |
| dc.identifier.uri | http://hdl.handle.net/2263/20794 | |
| dc.language.iso | en | en_US |
| dc.publisher | Health and Medical Publishing Group | en_US |
| dc.rights | Health and Medical Publishing Group | en_US |
| dc.subject | Human papillomavirus (HPV) vaccines | en_US |
| dc.title | Human papillomavirus (HPV) vaccines | en_US |
| dc.type | Article | en_US |
